Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Authors:
- Marcel M.C. HovensMHMarcel M.C. Hovens
- Jaapjan D. SnoepJSJaapjan D. Snoep
- Jeroen C.J. EikenboomJEJeroen C.J. Eikenboom
- Johanna G. van der BomJBJohanna G. van der Bom
- Bart J.A. MertensBMBart J.A. Mertens
- Menno V. HuismanMHMenno V. Huisman
- 1 February 2007
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 153 (2) , 175-181
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Prevalence of aspirin resistance in patients with type 2 diabetesActa Diabetologica, 2005
- Prevalence of aspirin resistance measured by PFA-100International Journal of Cardiology, 2005
- Screening for Aspirin Responsiveness After Transient Ischemic Attack and StrokeStroke, 2005
- The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosisAmerican Heart Journal, 2005
- Biological Assessment of Aspirin Efficacy on Healthy IndividualsStroke, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.Stroke, 1992
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981